Melatonin induces histone hyperacetylation in the rat brain

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 49-53

  Niles, Lennard P ^a   Pan, Yi ^a   Kang, Sean ^a   Lacoul, Ayush ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Epigenetic; ERK 1 2; Hippocampus; Histone acetylation; Melatonin; Striatum

Indexed keywords

HISTONE H3; HISTONE H4; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANIMAL TISSUE; ARTICLE; BRAIN; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; HIPPOCAMPUS; HISTONE ACETYLATION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ACETYLATION; ANIMALS; BRAIN; EPIGENESIS, GENETIC; HISTONES; MALE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84876419490     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.01.050     Document Type: Article

References (43)

1. Agez L., Laurent V., Pevet P., Masson-Pevet M., Gauer F. Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 2007, 144(2):522-530.
2. Ajamian F., Salminen A., Reeben M. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells. Neuroscience Letters 2004, 365(1):64-68.
3. Anhe G.F., Caperuto L.C., Pereira-Da-Silva M., Souza L.C., Hirata A.E., Velloso L.A., Cipolla-Neto J., Carvalho C.R. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. Journal of Neurochemistry 2004, 90(3):559-566.
4. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiological Reviews 2001, 81(3):1269-1304.
5. Becker-Andre M., Wiesenberg I., Schaeren-Wiemers N., Andre E., Missbach M., Saurat J.H., Carlberg C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. The Journal of Biological Chemistry 1994, 269(46):28531-28534.
6. Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. Journal of Pineal Research 2006, 40(1):1-9.
7. Brydon L., Roka F., Petit L., de Coppet P., Tissot M., Barrett P., Morgan P.J., Nanoff C., Strosberg A.D., Jockers R. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Molecular Endocrinology 1999, 13(12):2025-2038.
8. Butcher A.J., Prihandoko R., Kong K.C., McWilliams P., Edwards J.M., Bottrill A., Mistry S., Tobin A.B. Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code. The Journal of Biological Chemistry 2011, 286(13):11506-11518.
9. Castro L.M., Gallant M., Niles L.P. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. Journal of Neurochemistry 2005, 95(5):1227-1236.
10. Chan A.S., Lai F.P., Lo R.K., Voyno-Yasenetskaya T.A., Stanbridge E.J., Wong Y.H. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cellular Signalling 2002, 14(3):249-257.
11. Chen H., Lin R.J., Xie W., Wilpitz D., Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 1999, 98(5):675-686.
12. Cohen-Armon M., Visochek L., Rozensal D., Kalal A., Geistrikh I., Klein R., Bendetz-Nezer S., Yao Z., Seger R. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Molecular Cell 2007, 25(2):297-308.
13. Dubocovich M.L., Delagrange P., Krause D.N., Sugden D., Cardinali D.P., Olcese J. International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacological Reviews 2010, 62(3):343-380.
14. Glaser K.B., Staver M.J., Waring J.F., Stender J., Ulrich R.G., Davidsen S.K. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Molecular Cancer Therapeutics 2003, 2(2):151-163.
15. 3H]dopa in various regions of the brain. Journal of Neurochemistry 1966, 13(8):655-669.
16. Hsieh J., Eisch A.J. Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiology of Disease 2010, 39(1):73-84.
17. Hsieh J., Gage F.H. Chromatin remodeling in neural development and plasticity. Current Opinion of Cell Biology 2005, 17(6):664-671.
18. Ishii H., Tanaka N., Kobayashi M., Kato M., Sakuma Y. Gene structures, biochemical characterization and distribution of rat melatonin receptors. The Journal of Physiological Sciences 2009, 59(1):37-47.
19. Kilic U., Kilic E., Reiter R.J., Bassetti C.L., Hermann D.M. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. Journal of Pineal Research 2005, 38(1):67-71.
20. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128(4):693-705.
21. Lee E.R., McCool K.W., Murdoch F.E., Fritsch M.K. Dynamic changes in histone H3 phosphoacetylation during early embryonic stem cell differentiation are directly mediated by mitogen- and stress-activated protein kinase 1 via activation of MAPK pathways. The Journal of Biological Chemistry 2006, 281(30):21162-21172.
22. Liu Y., Denlinger C.E., Rundall B.K., Smith P.W., Jones D.R. Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. The Journal of Biological Chemistry 2006, 281(42):31359-31368.
23. Matsubara E., Bryant-Thomas T., Pacheco Quinto J., Henry T.L., Poeggeler B., Herbert D., Cruz-Sanchez F., Chyan Y.J., Smith M.A., Perry G., Shoji M., Abe K., Leone A., Grundke-Ikbal I., Wilson G.L., Ghiso J., Williams C., Refolo L.M., Pappolla M.A., Chain D.G., Neria E. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. Journal of Neurochemistry 2003, 85(5):1101-1108.
24. McFarland K.N., Das S., Sun T.T., Leyfer D., Xia E., Sangrey G.R., Kuhn A., Luthi-Carter R., Clark T.W., Sadri-Vakili G., Cha J.H. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS ONE 2012, 7(7):e41423.
25. Muller D.L., Unterwald E.M. In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. Journal of Pharmacology and Experimental Therapeutics 2004, 310(2):774-782.
26. Musshoff U., Riewenherm D., Berger E., Fauteck J.D., Speckmann E.J. Melatonin receptors in rat hippocampus: molecular and functional investigations. Hippocampus 2002, 12(2):165-173.
27. Niles L.P., Sathiyapalan A., Bahna S., Kang N.H., Pan Y. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. The International Journal of Neuropsychopharmacology 2012, 1-8.
28. Pandi-Perumal S.R., Trakht I., Srinivasan V., Spence D.W., Maestroni G.J., Zisapel N., Cardinali D.P. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Progress in Neurobiology 2008, 85(3):335-353.
29. Park H.T., Baek S.Y., Kim B.S., Kim J.B., Kim J.J. Developmental expression of 'RZR beta, a putative nuclear-melatonin receptor' mRNA in the suprachiasmatic nucleus of the rat. Neuroscience Letters 1996, 217(1):17-20.
30. Petit L., Lacroix I., de Coppet P., Strosberg A.D., Jockers R. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway. Biochemical Pharmacology 1999, 58(4):633-639.
31. Poeggeler B. Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 2005, 27(2):201-212.
32. Ramirez-Rodriguez G., Ortiz-Lopez L., Dominguez-Alonso A., Benitez-King G.A., Kempermann G. Chronic treatment with melatonin stimulates dendrite maturation and complexity in adult hippocampal neurogenesis of mice. Journal of Pineal Research 2011, 50(1):29-37.
33. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. Journal of Pineal Research 2004, 36(1):1-9.
34. Roy D., Belsham D.D. Melatonin receptor activation regulates GnRH gene expression and secretion in GT1-7 GnRH neurons. Signal transduction mechanisms. The Journal of Biological Chemistry 2002, 277(1):251-258.
35. Sahar S., Sassone-Corsi P. Circadian rhythms and memory formation: regulation by chromatin remodeling. Frontiers in Molecular Neuroscience 2012, 5:37.
36. Sharma R., McMillan C.R., Tenn C.C., Niles L.P. Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. Brain Research 2006, 1068(1):230-236.
37. Sharma R., Ottenhof T., Rzeczkowska P.A., Niles L.P. Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. Journal of Pineal Research 2008, 45:277-284.
38. Shimazu T., Hirschey M.D., Newman J., He W., Shirakawa K., Le Moan N., Grueter C.A., Lim H., Saunders L.R., Stevens R.D., Newgard C.B., Farese R.V., de Cabo R., Ulrich S., Akassoglou K., Verdin E. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013, 339(6116):211-214.
39. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expression 1996, 5(4-5):245-253.
40. Wan Q., Man H.Y., Liu F., Braunton J., Niznik H.B., Pang S.F., Brown G.M., Wang Y.T. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors. Nature Neuroscience 1999, 2(5):401-403.
41. Witt-Enderby P.A., MacKenzie R.S., McKeon R.M., Carroll E.A., Bordt S.L., Melan M.A. Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor. Cell Motility and the Cytoskeleton 2000, 46(1):28-42.
42. Woehler A., Ponimaskin E.G. G protein-mediated signaling: same receptor, multiple effectors. Current Molecular Pharmacology 2009, 2(3):237-248.
43. Wu X., Chen P.S., Dallas S., Wilson B., Block M.L., Wang C.C., Kinyamu H., Lu N., Gao X., Leng Y., Chuang D.M., Zhang W., Lu R.B., Hong J.S. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. The International Journal of Neuropsychopharmacology 2008, 11(8):1123-1134.